Clinical‐stage natural psychedelic drug development company, Filament Health (NEOE:FH:CA) (OTCQB:FLHLF) expects to complete the financing for net proceeds of approximately C$0.9M. The company also ...
Kontrol Technologies Corp. (Cboe CA:KNR) (OTCQB:KNRLF) ( "Kontrol" or the "Company") announces the that it has completed its ...
"As a longstanding supporter of Filament Health and its mission, we are pleased to continue our commitment to the Company," said Vadim Uzberg, Partner at Negev Capital. "Filament remains well ...
Cboe Canada is home to some of the most innovative Canadian and international growth companies, ETFs from Canada's largest ETF issuers, and more than 100 Canadian Depositary Receipts (CDRs). Cboe ...
Canadian diamond miner Lipari Mining (Cboe CA: LML) has officially begun trading on the Cboe Canada stock exchange following the completion of its recently announced reverse takeover (RTO).
Which ETFs should you invest in? Which ones best suit your risk tolerance? What about personal ethics? Check out the MoneySense ETF screener. Bookmark it as it’s updated weekly. If you’re ...
Clinical‐stage natural psychedelic drug development company, Filament Health (NEOE:FH:CA) (OTCQB:FLHLF) expects to complete the financing for net proceeds of approximately C$0.9M. The company ...
Cboe Canada Continues Support of the Mining Industry with the Public Listing of Lipari Mining Ltd. Cboe Canada Inc. (“Cboe Canada”) is proud to announce the public listing of Lipari Mining Ltd ...
Kontrol Technologies Corp., a Canadian public company, is a leader in smart buildings and cities through IoT, Cloud and SaaS technology. Kontrol provides solutions and services to its customers to ...
"As a longstanding supporter of Filament Health and its mission, we are pleased to continue our commitment to the Company," said Vadim Uzberg, Partner at Negev Capital. "Filament remains ...
VANCOUVER, BC, April 3, 2025 /CNW/ - Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) ("Filament" or the "Company"), a clinical‐stage natural psychedelic drug development company, ...
Financing driven by existing investor Negev and Filament's Board of Directors Company also announces intention to voluntarily delist from Cboe Canada VANCOUVER, BC, April 3, 2025 /CNW/ - Filament ...